{"schema_version":"secwatch.filing_event.v1","accession":"0000313616-23-000006","form_type":"8-K","ticker":"DHR","cik":"0000313616","company_name":"DANAHER CORP /DE/","filed_at":"2023-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.586360+00:00","generated_at":"2026-06-20T11:05:59.492347+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Danaher Q4 2022 EPS $2.99, revenue $8.4B; full-year core growth 9.5%","bullets":["Q4 2022 net earnings $2.2B ($2.99 diluted EPS); adjusted EPS $2.87, up 6.5% YoY.","Q4 revenue $8.4B (+2.5% YoY); non-GAAP core revenue growth 7.5% (base business core 7.5%).","Full year 2022 net earnings $7.1B ($9.66 EPS); adjusted EPS $10.95 (+9.0% YoY); revenue $31.5B (+7.0%).","Full year operating cash flow $8.5B; free cash flow $7.4B.","Guidance: Q1 2023 base business core revenue growth mid-single digits; full-year 2023 high-single digits. Revises base business definition to exclude COVID-19 testing/vaccines/therapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0000313616-23-000006","json":"https://secwatch.observer/filing/0000313616-23-000006.json","markdown":"https://secwatch.observer/filing/0000313616-23-000006.md","text":"https://secwatch.observer/filing/0000313616-23-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000006/0000313616-23-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000006/dhr-20230124.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T11:05:59.492347+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3501557c4839b12dc2dd86a31bbb94bb0729311c","claim":"DANAHER CORP /DE/ reported the full year 2022 results: revenue $31.5 billion, net income $7.1 billion, EPS $9.66 per diluted common share. Guidance initiated.","evidence_excerpt":"For the full year 2022, net earnings were $7.1 billion, or $9.66 per diluted common share which represents a 13.5% year-over-year increase. Non-GAAP adjusted diluted net earnings per common share for the year were $10.95, which represents a 9.0% increase over the comparable 2021 amount. Revenues for the full year 2022 increased 7.0% to $31.5 billion.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000006/0000313616-23-000006-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year 2022"},{"label":"Revenue","value":"$31.5 billion"},{"label":"Net income","value":"$7.1 billion"},{"label":"EPS","value":"$9.66 per diluted common share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"436624ebd426fb3df6b4dce03177027444315bec","claim":"DANAHER CORP /DE/ reported the quarter ended December 31, 2022 results: revenue $8.4 billion, net income $2.2 billion, EPS $2.99 per diluted common share. Guidance initiated.","evidence_excerpt":"For the quarter ended December 31, 2022, net earnings were $2.2 billion, or $2.99 per diluted common share which represents a 25.0% year-over-year increase from the comparable 2021 period. Non-GAAP adjusted diluted net earnings per common share were $2.87 which represents a 6.5% increase over the comparable 2021 period. Revenues increased 2.5% year-over-year in the fourth quarter of 2022 to $8.4 billion.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000006/0000313616-23-000006-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2022"},{"label":"Revenue","value":"$8.4 billion"},{"label":"Net income","value":"$2.2 billion"},{"label":"EPS","value":"$2.99 per diluted common share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}